Loading clinical trials...
Loading clinical trials...
The purpose of this study is to decrease the likelihood of composite postpartum hemorrhage (PPH) morbidity, which consists of i) Estimated or quantified blood loss of 1,500 mL or more, ii) transfusion...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The University of Texas Health Science Center, Houston
NCT07187544 · Postpartum Hemorrhage (Primary)
NCT07199803 · Postpartum Hemorrhage (Primary)
NCT07229573 · Gamification, Gamification in Health Education, and more
NCT07034924 · Postpartum Hemorrhage
NCT06930391 · Postpartum Hemorrhage (Primary)
The University of Texas Health Science Center at Houston
Houston, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions